ISPE

JUNE 2, 2023

It involves a wide variety of analytical technologies, requires well trained analysts, and is a major component of the critical path to regulatory submissions and product release. For more information, please contact: communities@ispe.org. Quality Quality Control (QC)

Method Validation 98

Method Validation 98

Pharmaceutical Technology

MARCH 8, 2023

Global science and technology innovator Danaher has entered a strategic collaboration with the University of Pennsylvania for cellular immunotherapies to address manufacturing challenges impacting cell therapy uptake. The multi-year collaboration aims to develop new technologies which will help in improving clinical outcomes for patients.

Communication 97

Communication FDA 97

Pharmaceutical Technology

DECEMBER 21, 2022

This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Free Whitepaper.

Vaccines 140

Vaccines Communication 140

Pharmaceutical Technology

FEBRUARY 9, 2023

The collaboration is aimed at discovering and developing new advanced treatments for genitourinary (GU) tumours as well as other related serious diseases using ReviR’s RNA-targeted technologies. ReviR combines computational and high throughput drug discovery technologies to deliver advanced medicines to patients.

Communication 96

Communication 96

Pharmaceutical Technology

FEBRUARY 23, 2023

This collaboration will enable us to utilise our cutting-edge GMP plasmid manufacturing platform technology to support the development of mRNA-based Covid-19 vaccine and its therapeutic candidates.” Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Vaccines 115

Vaccines Communication 115

Pharmaceutical Technology

MAY 26, 2023

Krystal Biotech has received approval from the US Food and Drug Administration for topical gene therapy VYJUVEK to treat dystrophic epidermolysis bullosa (DEB) in adults and in children aged six months and above. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

FDA 105

FDA 105

Pharmaceutical Technology

MARCH 28, 2023

Under the terms of the deal, the company will receive non-exclusive rights to CRISPR/Cas9, a gene-editing technology of CRISPR Therapeutics, for the development of potentially curative T1D cell therapies. The gene-editing technology allows for precise, directed changes to genomic DNA.

Communication 94

Communication 94

Pharmaceutical Technology

FEBRUARY 16, 2023

The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. Under the deal, MD Anderson and Xilis aim to advance the development of drug and discovery projects using the MOS technology.

Communication 96

Communication 96

Pharmaceutical Technology

JUNE 19, 2023

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

DECEMBER 5, 2022

With an initial focus on enchaining mRNA technology and developing a vaccine for Chlamydia, the research at the hub is anticipated to commence in the first quarter of next year. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Vaccines 98

Vaccines Communication Immunization 98

Pharmaceutical Technology

DECEMBER 8, 2022

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content. The post Kite and Daiichi Sankyo update cell therapy licensing agreement appeared first on Pharmaceutical Technology. Free Whitepaper.

Communication 122

Communication Immunization Hospitals 122

IDStewardship

FEBRUARY 25, 2024

In this article four experts from bioMérieux discuss microbiology strategies to advance antimicrobial stewardship, reflecting on a recent Xchat (Twitter Chat) on the topic. While the global AMR statistics are powerful, having local data makes information more relatable and actionable. In my practice, we always reported the MIC.

Communication 208

Communication Patient Care Hospitals 208

ISPE

MAY 16, 2023

Yet despite many of the external challenges the core technology behind blockchains has remained secure, available, and immutable – just as they were designed to do. According to a report by Grand View Research, the global blockchain technology market in healthcare is expected to grow at a compound annual growth rate (CAGR) of 66.1%

Compounding 98

Compounding 98

pharmaphorum

SEPTEMBER 28, 2020

The FDA has launched its Digital Health Center of Excellence (DHCoE), as the agency continues with its commitment to advancing use of technology such as mobile health devices, software and wearables to create medical products. The post FDA launches Digital Health Center of Excellence appeared first on.

FDA 141

FDA 141

IDStewardship

APRIL 13, 2023

PACCARB provides advice, information, and recommendations to the Health and Human Services Secretary (HHS) regarding programs and policies intended to support and evaluate the implementation of U.S. Today this Taskforce is known as The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, or PACCARB.

Hospitals 236

Hospitals Documentation Communication Patient Care 236

Pharmaceutical Technology

JANUARY 17, 2023

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content. The post Hospital Universitario and Josep Carreras develop cell therapy for leukaemia appeared first on Pharmaceutical Technology. Free Whitepaper.

Hospitals 110

Hospitals Chemotherapy Communication Immunization 110

PQA

SEPTEMBER 13, 2023

The certificate proceeds with foundational information about health equity and social determinants of health in medication use quality. Learners will then explore special topics impacting quality, including health information technology and navigating the quality regulatory environment. PQA members receive a 50% discount.

Patient Care 52

Patient Care 52

Pharmaceutical Technology

APRIL 21, 2023

Moderna will gain access to IBM’s quantum computing systems, an emerging technology that harnesses quantum mechanics for solving complex problems that cannot be handled efficiently by classical computers. IBM will also provide its knowledge to help Moderna explore the potential use cases of quantum technologies in life sciences.

98

98

Pharmaceutical Technology

MARCH 20, 2023

“The collaboration will apply the mRNA technologies to induce antigen-specific immune tolerances, and RVAC is committed to becoming a leader in this field.” Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Vaccines 98

Vaccines Immunization Communication 98

Pharmaceutical Technology

DECEMBER 18, 2022

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content. The post EMA CHMP recommends Moderna’s Covid-19 booster for children appeared first on Pharmaceutical Technology. Free Whitepaper.

Vaccines 121

Vaccines Communication 121

pharmaphorum

JANUARY 18, 2022

Envision Pharma’s scientific solutions division lead Rebecca Goldstein, discusses this topic and other developments that cancer patients and their loved ones should be paying attention to. Developments to watch. Cancer patients and their loved ones can easily get overwhelmed by the sheer number of choices available.

96

96

pharmaphorum

JUNE 1, 2022

The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. However, with virtual reality (VR), one element of the broader digital health ecosystem, this act of placing a technology and its use within healthcare becomes trickier. The training challenge.

Vaccines 145

Vaccines Immunization Hospitals Packaging 145

ISPE

SEPTEMBER 21, 2023

This track will delve into five important topics where you will hear from speakers who will help answer your questions and provide you with the necessary information to make confident decisions regarding any updated changes to your facility, equipment, procedures, and documents. The 2023 ISPE Pharma 4.0™

Documentation 98

Documentation FDA 98

pharmaphorum

SEPTEMBER 21, 2020

The new deal adds more than 80,000 questions and answers to the repertoire of the Alexa virtual assistant, which provides information, entertainment and advice to users on voice command via devices such as Amazon’s Echo smart speakers. Amazon meanwhile has made no secret of its ambitions in healthcare, and not just as a content channel.

Mayo Clinic 125

Mayo Clinic HIPAA Insurance 125

Pharmaceutical Technology

JANUARY 5, 2023

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content. The post Capsida Biotherapeutics and Prevail to develop CNS gene therapies appeared first on Pharmaceutical Technology. Free Whitepaper.

Communication 95

Communication 95

Pharmaceutical Technology

NOVEMBER 29, 2022

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content. The post AstraZeneca enters $320m deal to acquire Neogene appeared first on Pharmaceutical Technology. Free Whitepaper.

Communication 111

Communication 111

pharmaphorum

NOVEMBER 2, 2022

With pharmaphorum fully in attendance today, expect coverage of a wide range of topics, within a variety of formats, all united by a shared goal of seeking sustainable change for Britain, whilst bearing in mind her role upon the global stage at this critical juncture in history.

91

91

ISPE

FEBRUARY 6, 2023

This summit ISPE joined with two co-organizers, four sponsors, 39 industry experts, and nearly 1,000 participants in this wonderful academic information sharing. CYTIVA, Tofflon Technology Group Co., Truking Technology Co., Let’s review the exciting content of the conference together! Glaser Life Sciences (Shanghai) Co.,

Communication 98

Communication 98

Pharmaceutical Technology

DECEMBER 12, 2022

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content. The post Kite and Arcellx enter partnership for multiple myeloma therapy development appeared first on Pharmaceutical Technology. Free Whitepaper.

Communication 105

Communication 105

Pharmaceutical Technology

APRIL 3, 2023

Amidst industry-wide shortages, biotechnology companies are moving to shore up viral vector production – an important component of many therapeutic technologies. GlobalData, the parent company of Pharmaceutical Technology, outlines a rise in gene therapy trials in 2023, in line with the growing market Fáber describes.

98

98

ISPE

NOVEMBER 23, 2022

The Symposium program comprised a wide range of presentations and panel discussions on GMP-related topics, which included participation from Heads of Medicines Agencies, Heads of GMP Inspectorates, official PIC/S representatives and ISPE. And it is important that our regulatory responsibilities allow innovation to thrive.

Documentation 98

Documentation FDA Communication 98

Pharmaceutical Technology

FEBRUARY 23, 2023

The collaboration will combine the mRNA platform of Moderna with the gene editing technologies suite, including the base editing capabilities of Life Edit for the development of curative therapies to treat challenging genetic diseases. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Communication 59

Communication 59

Pharmaceutical Technology

MARCH 10, 2023

In an email to Pharmaceutical Technology , an NHSBT spokesperson said the centre will “support early phase clinical trials and preclinical work, providing a route to eventual commercial scale production”. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Communication 105

Communication 105

Pharmaceutical Technology

JUNE 13, 2023

The British investment trust Syncona Limited launched the new ophthalmic gene therapy company by combining Applied Genetic Technologies Corporation’s (AGTC’s) late-stage X-linked retinitis pigmentosa (XLRP) programme with two proprietary preclinical programmes. GlobalData is the parent company of Pharmaceutical Technology.

98

98

Pharmaceutical Technology

MAY 23, 2023

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content. In 2022, Avrobio’s investigational gene therapy, AVR-RD-04, received a rare paediatric disease designation from the US Food and Drug Administration.

103

103

Pharmaceutical Technology

JUNE 1, 2023

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drug delivery technologies. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Vaccines 97

Vaccines 97

pharmaphorum

DECEMBER 15, 2022

Social media has become an important way for HCPs to exchange ideas, information, and questions, and to learn about new products and emerging data. Use this as an opportunity to listen and understand the kinds of topics they are interested in talking about or learning more about. Sharing information and developing partnerships.

Communication 92

Communication Vaccines FDA 92